Immuneering Corporation (IMRX)

Immuneering Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	36.14	59.41	72.64	74.89	37.09
Short-Term Investments	-	26.26	32.89	74.31	-
Cash & Short-Term Investments	36.14	85.67	105.52	149.2	37.09
Cash Growth	-57.81%	-18.82%	-29.27%	302.26%	169.12%
Receivables	-	-	0.01	0.25	0.5
Prepaid Expenses	3.44	3.42	3.21	2.89	0.14
Total Current Assets	39.59	89.08	108.75	152.33	37.73
Property, Plant & Equipment	4.79	5.4	5.78	6.13	0.68
Long-Term Investments	-	-	-	1	-
Goodwill	6.69	6.69	6.69	6.7	-
Other Intangible Assets	0.35	0.38	0.41	0.44	-
Other Long-Term Assets	1.3	1.03	0.74	0.1	0.01
Total Assets	52.71	102.58	122.37	166.7	38.42
Accounts Payable	1.96	2.11	3.15	1.39	1.48
Accrued Expenses	4.97	5.17	4.5	3.97	0.7
Current Portion of Leases	0.34	0.3	0.38	0.27	0.08
Other Current Liabilities	0.23	0.26	0.02	-	-
Total Current Liabilities	7.5	7.85	8.05	5.63	2.26
Long-Term Leases	3.82	4.16	4.46	5.09	0.54
Total Liabilities	11.33	12.01	12.52	10.72	2.8
Common Stock	0.03	0.03	0.03	0.03	0
Additional Paid-In Capital	265.65	253.81	219.64	215.28	3.25
Retained Earnings	-224.3	-163.26	-109.79	-59.27	-25.74
Comprehensive Income & Other	-	-0	-0.03	-0.05	-
Total Common Equity	41.39	90.58	109.85	155.98	-22.48
Shareholders' Equity	41.39	90.58	109.85	155.98	35.62
Total Liabilities & Equity	52.71	102.58	122.37	166.7	38.42
Total Debt	4.16	4.46	4.84	5.36	0.62
Net Cash (Debt)	31.98	81.2	100.68	144.83	36.47
Net Cash Growth	-60.61%	-19.35%	-30.48%	297.13%	255.02%
Net Cash Per Share	1.07	2.86	3.82	10.64	7.37
Filing Date Shares Outstanding	35.89	29.28	26.44	26.38	4.95
Total Common Shares Outstanding	31.05	29.27	26.42	26.32	4.95
Working Capital	32.08	81.24	100.69	146.7	35.48
Book Value Per Share	1.33	3.09	4.16	5.93	-4.54
Tangible Book Value	34.35	83.51	102.75	148.84	-22.48
Tangible Book Value Per Share	1.11	2.85	3.89	5.65	-4.54
Machinery	1.91	1.83	1.5	0.83	0.19
Leasehold Improvements	0.3	0.3	0.29	0.15	-

Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q